• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于监测、流行病学和最终结果计划的预测T1期乳腺癌淋巴结转移的列线图

A Nomogram Predicting Lymph Node Metastasis in T1 Breast Cancer based on the Surveillance, Epidemiology, and End Results Program.

作者信息

Zhao Ya-Xin, Liu Yi-Rong, Xie Shao, Jiang Yi-Zhou, Shao Zhi-Ming

机构信息

Department of Breast Surgery, Fudan University Shanghai Cancer Center; Cancer Institute, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai 200032, People's Republic of China.

Department of Oncology, Shanghai Medical College, Fudan University, P. R. China.

出版信息

J Cancer. 2019 May 27;10(11):2443-2449. doi: 10.7150/jca.30386. eCollection 2019.

DOI:10.7150/jca.30386
PMID:31258749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6584352/
Abstract

Patients with early stage breast cancer with lymph nodes metastasis were proven to have more aggressive biologically phenotypes. This study aimed to build a nomogram to predict lymph node metastasis in patients with T1 breast cancer. We identified female patients with T1 breast cancer diagnosed between 2010 and 2014 in the Surveillance, Epidemiology and End Results database. The patients were randomized into training and validation sets. Univariate and multivariate logistic regressions were carried out to assess the relationships between lymph node metastasis and clinicopathological characteristics. A nomogram was developed and validated by a calibration curve and receptor operating characteristic curve analysis. Age, race, tumour size, tumour primary site, pathological grade, oestrogen receptor (ER) status, progesterone receptor (PR) status and human epidermal growth factor receptor 2 (HER2) status were independent predictive factors of positive lymph node metastasis in T1 breast cancer. Increasing age, tumour size and pathological grade were positively correlated with the risk of lymph node metastasis. We developed a nomogram to predict lymph node metastasis and further validated it in a validation set, with areas under the receiver operating characteristic curves of 0.733 and 0.741 in the training and validation sets, respectively. A better understanding of the clinicopathological characteristics of T1 breast cancer patients might important for assessing their lymph node status. The nomogram developed here, if further validated in other large cohorts, might provide additional information regarding lymph node metastasis. Together with sentinel lymph node biopsy, this nomogram can help comprehensively predict lymph node metastasis.

摘要

早期乳腺癌伴淋巴结转移的患者被证实具有更具侵袭性的生物学表型。本研究旨在构建一种列线图,以预测T1期乳腺癌患者的淋巴结转移情况。我们在监测、流行病学和最终结果数据库中确定了2010年至2014年期间诊断为T1期乳腺癌的女性患者。这些患者被随机分为训练集和验证集。进行单因素和多因素逻辑回归分析,以评估淋巴结转移与临床病理特征之间的关系。通过校准曲线和受试者工作特征曲线分析开发并验证了列线图。年龄、种族、肿瘤大小、肿瘤原发部位、病理分级、雌激素受体(ER)状态、孕激素受体(PR)状态和人表皮生长因子受体2(HER2)状态是T1期乳腺癌淋巴结转移阳性的独立预测因素。年龄、肿瘤大小和病理分级的增加与淋巴结转移风险呈正相关。我们开发了一种列线图来预测淋巴结转移,并在验证集中进一步验证,训练集和验证集的受试者工作特征曲线下面积分别为0.733和0.741。更好地了解T1期乳腺癌患者的临床病理特征可能对评估其淋巴结状态很重要。此处开发的列线图,如果在其他大型队列中进一步验证,可能会提供有关淋巴结转移的额外信息。与前哨淋巴结活检一起,这种列线图可以帮助全面预测淋巴结转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c0/6584352/7c54b2151a94/jcav10p2443g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c0/6584352/f0cdeebe0820/jcav10p2443g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c0/6584352/7a660e083e4c/jcav10p2443g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c0/6584352/7c54b2151a94/jcav10p2443g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c0/6584352/f0cdeebe0820/jcav10p2443g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c0/6584352/7a660e083e4c/jcav10p2443g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c0/6584352/7c54b2151a94/jcav10p2443g003.jpg

相似文献

1
A Nomogram Predicting Lymph Node Metastasis in T1 Breast Cancer based on the Surveillance, Epidemiology, and End Results Program.基于监测、流行病学和最终结果计划的预测T1期乳腺癌淋巴结转移的列线图
J Cancer. 2019 May 27;10(11):2443-2449. doi: 10.7150/jca.30386. eCollection 2019.
2
Nomogram for Predicting Lymph Node Involvement in Triple-Negative Breast Cancer.预测三阴性乳腺癌淋巴结受累情况的列线图
Front Oncol. 2020 Dec 4;10:608334. doi: 10.3389/fonc.2020.608334. eCollection 2020.
3
Development and validation of a nomogram for prediction of lymph node metastasis in early-stage breast cancer.早期乳腺癌淋巴结转移预测列线图的开发与验证
Gland Surg. 2021 Mar;10(3):901-913. doi: 10.21037/gs-20-782.
4
Development of a prognostic nomogram for lymph node positive HR/HER2 breast cancer patients: a study of SEER database and a Chinese cohort.淋巴结阳性HR/HER2乳腺癌患者预后列线图的开发:一项基于SEER数据库和中国队列的研究
Gland Surg. 2023 Nov 24;12(11):1541-1553. doi: 10.21037/gs-23-177. Epub 2023 Nov 16.
5
Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis.新辅助化疗后前哨淋巴结阳性患者非前哨淋巴结转移的预测因素:预测非前哨淋巴结转移的列线图。
Clin Breast Cancer. 2017 Nov;17(7):550-558. doi: 10.1016/j.clbc.2017.03.014. Epub 2017 Apr 6.
6
Development and validation of an ultrasonography and clinicopathological features-based nomogram for non-sentinel lymph node metastasis.基于超声检查和临床病理特征的非前哨淋巴结转移列线图的开发与验证
Gland Surg. 2023 Mar 31;12(3):402-414. doi: 10.21037/gs-23-58. Epub 2023 Mar 24.
7
Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients.乳腺癌患者前哨淋巴结转移的危险因素及 MSKCC 列线图的验证研究。
Jpn J Clin Oncol. 2012 Nov;42(11):1002-7. doi: 10.1093/jjco/hys150.
8
Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison.MSKCC 列线图预测前哨淋巴结阳性乳腺癌患者非前哨淋巴结转移的验证:国际比较。
Int J Surg. 2013;11(7):538-43. doi: 10.1016/j.ijsu.2013.05.005. Epub 2013 May 22.
9
A Nomogram for Predicting the Pathological Response of Axillary Lymph Node Metastasis in Breast Cancer Patients.乳腺癌患者腋窝淋巴结转移病理反应预测的列线图。
Sci Rep. 2016 Aug 31;6:32585. doi: 10.1038/srep32585.
10
A Clinical Nomogram for Predicting Lymph Node Metastasis in Penile Cancer: A SEER-Based Study.用于预测阴茎癌淋巴结转移的临床列线图:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Front Oncol. 2021 Mar 9;11:640036. doi: 10.3389/fonc.2021.640036. eCollection 2021.

引用本文的文献

1
Development of a Machine Learning Model Integrating Pathomics and Clinical Data to Predict Axillary Lymph Node Metastasis in Breast Cancer: A Two-Center Study.整合病理组学和临床数据的机器学习模型用于预测乳腺癌腋窝淋巴结转移的研究:一项双中心研究
Cancer Rep (Hoboken). 2025 Sep;8(9):e70302. doi: 10.1002/cnr2.70302.
2
Sentinel lymph node biopsy omission in early-stage breast cancer: current evidence and clinical practice.早期乳腺癌前哨淋巴结活检的遗漏:当前证据与临床实践
Front Oncol. 2025 Jun 19;15:1598730. doi: 10.3389/fonc.2025.1598730. eCollection 2025.
3
Preoperative ultrasonography-guided core-needle biopsy-based factors for predicting the upgrade of axillary lymph nodes in breast cancer.

本文引用的文献

1
Development of nomograms to predict axillary lymph node status in breast cancer patients.预测乳腺癌患者腋窝淋巴结状态的列线图的开发。
BMC Cancer. 2017 Aug 23;17(1):561. doi: 10.1186/s12885-017-3535-7.
2
Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.早期乳腺癌患者前哨淋巴结活检:美国临床肿瘤学会临床实践指南更新。
J Clin Oncol. 2014 May 1;32(13):1365-83. doi: 10.1200/JCO.2013.54.1177. Epub 2014 Mar 24.
3
A breast cancer nomogram for prediction of non-sentinel node metastasis - validation of fourteen existing models.
基于术前超声引导下粗针穿刺活检的预测乳腺癌腋窝淋巴结升级的因素
Quant Imaging Med Surg. 2025 Jun 6;15(6):5126-5136. doi: 10.21037/qims-24-1257. Epub 2025 Jun 3.
4
Role of Progesterone Receptor Level in Predicting Axillary Lymph Node Metastasis in Clinical T1-T2N0 Luminal Type Breast Cancer.孕激素受体水平在预测临床T1-T2N0腔面型乳腺癌腋窝淋巴结转移中的作用
Medicina (Kaunas). 2025 Apr 12;61(4):710. doi: 10.3390/medicina61040710.
5
Predicting sentinel lymph node metastasis in breast cancer: a study based on the SEER database.预测乳腺癌前哨淋巴结转移:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Clin Exp Med. 2025 Mar 13;25(1):82. doi: 10.1007/s10238-025-01591-5.
6
Identification of sentinel lymph node macrometastasis in breast cancer by deep learning based on clinicopathological characteristics.基于临床病理特征的深度学习在乳腺癌前哨淋巴结宏转移中的鉴定。
Sci Rep. 2024 Nov 6;14(1):26970. doi: 10.1038/s41598-024-78040-y.
7
A new prediction nomogram of non-sentinel lymph node metastasis in cT1-2 breast cancer patients with positive sentinel lymph nodes.一种新的预测 cT1-2 期前哨淋巴结阳性乳腺癌患者非前哨淋巴结转移的列线图。
Sci Rep. 2024 Apr 26;14(1):9596. doi: 10.1038/s41598-024-60198-0.
8
Unveiling the best predictive models for early‑onset metastatic cancer: Insights and innovations (Review).揭示早期转移性癌症最佳预测模型:洞察与创新(综述)。
Oncol Rep. 2024 Apr;51(4). doi: 10.3892/or.2024.8719. Epub 2024 Mar 8.
9
Incidence and risk factors of lymph node metastasis in breast cancer patients without preoperative chemoradiotherapy and neoadjuvant therapy: analysis of SEER data.未接受术前放化疗和新辅助治疗的乳腺癌患者淋巴结转移的发生率及危险因素:监测、流行病学与最终结果(SEER)数据的分析
Gland Surg. 2023 Nov 24;12(11):1508-1524. doi: 10.21037/gs-23-258. Epub 2023 Nov 17.
10
Identifying clinicopathological risk factors for regional lymph node metastasis in Chinese patients with T1 breast cancer: a population-based study.中国T1期乳腺癌患者区域淋巴结转移的临床病理危险因素识别:一项基于人群的研究。
Front Oncol. 2023 Aug 4;13:1217869. doi: 10.3389/fonc.2023.1217869. eCollection 2023.
用于预测非前哨淋巴结转移的乳腺癌列线图——十四种现有模型的验证
Asian Pac J Cancer Prev. 2014;15(3):1481-8. doi: 10.7314/apjcp.2014.15.3.1481.
4
Characteristics and clinical outcome of T1 breast cancer: a multicenter retrospective cohort study.T1期乳腺癌的特征与临床结局:一项多中心回顾性队列研究
Ann Oncol. 2014 Mar;25(3):623-628. doi: 10.1093/annonc/mdt532. Epub 2014 Jan 7.
5
Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients.乳腺癌患者前哨淋巴结转移的危险因素及 MSKCC 列线图的验证研究。
Jpn J Clin Oncol. 2012 Nov;42(11):1002-7. doi: 10.1093/jjco/hys150.
6
Validation over time of a nomogram including HER2 status to predict the sentinel node positivity in early breast carcinoma.时间验证包括 HER2 状态的列线图预测早期乳腺癌前哨淋巴结阳性的价值。
Eur J Surg Oncol. 2012 Dec;38(12):1211-7. doi: 10.1016/j.ejso.2012.08.007. Epub 2012 Sep 3.
7
The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma.分子亚型分类是早期乳腺癌前哨淋巴结阳性的决定因素。
PLoS One. 2011;6(5):e20297. doi: 10.1371/journal.pone.0020297. Epub 2011 May 31.
8
Effect of very small tumor size on cancer-specific mortality in node-positive breast cancer.非常小的肿瘤大小对淋巴结阳性乳腺癌患者癌症特异性死亡率的影响。
J Clin Oncol. 2011 Jul 1;29(19):2619-27. doi: 10.1200/JCO.2010.29.5907. Epub 2011 May 23.
9
The sentinel node procedure in breast cancer: nuclear medicine as the starting point.乳腺癌前哨淋巴结活检术:核医学作为起点。
J Nucl Med. 2011 Mar;52(3):405-14. doi: 10.2967/jnumed.110.081711. Epub 2011 Feb 14.
10
High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller.人表皮生长因子受体2阳性、肿瘤大小为1厘米或更小且无淋巴结转移的乳腺癌患者复发风险高。
J Clin Oncol. 2009 Dec 1;27(34):5700-6. doi: 10.1200/JCO.2009.23.2025. Epub 2009 Nov 2.